Courts in California, New Jersey, and Pennsylvania are determining how to manage lawsuits filed by individuals who, through a Reglan lawyer, are seeking compensation for injuries incurred as a result of using the drug or its generic variants.
Though Reglan has been on the market since 1986, very little has been communicated to consumers about the drug’s side effects. Reglan manufacturers have said that Reglan tardive dyskinesia only occurs in approximately .02 percent of patients. However, some researchers cited by the FDA have said this estimate is grossly underrated and that the risk of developing Reglan tardive dyskinesia is more than 100 times greater in patients using large doses for long periods of time.
Although the Food and Drug Administration (FDA) approved short-term use of Reglan, about 30 percent of physicians prescribed Reglan for more than 12 months based on manufacturer reports of minimal side effects. Because physicians prescribed long-term Reglan use based on insufficient information provided by manufacturers, those who have used Reglan for more than 12 weeks often argue through a Reglan lawyer that the company intentionally failed its duty to warn the public about the drug’s side effects.
A mass tort has been filed in the Court of Common Pleas in Philadelphia County as well as the San Francisco Superior Court. The New Jersey Superior Court has created a centralized management to handle more than 1,000 plaintiffs who, with the aid of a Reglan lawyer, have filed a lawsuit.
For more information on Reglan and its side effects visit our website today.